[1]JournalofPharmaceuticalSciences,1980,vol.69,p.850-851
1701-69-5
75055-73-1
5693-75-4
60148-10-9
79251-07-3
1513267-39-4
1704064-31-2 | 4-Methyl-3-(3-(4-methylpiperazin-1-yl)propoxy)phenylboronic acid | AA00ARMH | MFCD28384332
1699-40-7 | N-[4-(Benzyloxy)-3-Methoxyphenethyl]-2-[3-(benzyloxy)-4-Methoxyphenyl]acetaMide | AA00AS48 | MFCD00183333
160158-05-4 | Fmoc-Lys(biotinyl-e-aminocaproyl)-OH | AA00ASJ2 | MFCD00672715
179686-66-9 | tert-butyl 2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepine-4(5H)-carboxylate | AA00AT3S | MFCD21222599
1620515-86-7 | 6-Bromo-7-methoxyquinoline | AA00ATDA | MFCD29059222
16956-42-6 | 4-Benzylsemicarbazide | AA00AVBE | MFCD11212597
1929-73-3 | 2-Butoxyethyl-2-(2,4-dichlorophenoxy)acetate | AA00AY74 | MFCD00126849
153436-38-5 | GAVESTINEL | AA00B0S0 | MFCD00923984
1706-90-7 | Methyl diphenylphosphinate | AA00B489 | MFCD32206186
17989-41-2 | [R,(-)]-1-O-Phosphono-D-glycerol | AA00B64F | MFCD00236373